These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17469340)

  • 1. [Metabolic support of the ischemic heart during cardiac surgery].
    Luna Ortiz P; Serrano Valdés X; Rojas Pérez E; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S121-36. PubMed ID: 17469340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On metabolic therapeutics G-I-K in surgery of cardiac patients].
    de Micheli A; Medrano GA
    Arch Cardiol Mex; 2004; 74(3):215-9. PubMed ID: 15559874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac metabolism in ischemic heart disease.
    Opie LH
    Arch Mal Coeur Vaiss; 1999 Dec; 92(12):1755-60. PubMed ID: 10665328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic intervention for the ischemic and post-ischemic heart.
    Svedjeholm R; Håkanson E; Szabó Z
    Wien Klin Wochenschr; 1999 Jul; 111(13):501-11. PubMed ID: 10444803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucose-insulin-potassium (GIK) solution: cardioprotective effects of insulin].
    Rojas Pérez EM; Luna Ortiz P; Serrano Valdez X; Fernández Rivera BJ; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S144-51. PubMed ID: 17469342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucose-insulin-potassium (GIK) in prevention and therapy of myocardial ischemia].
    Haider W; Hiesmayr M
    Wien Klin Wochenschr; 2000 Apr; 112(7):310-21. PubMed ID: 10849955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucose-insulin-potassium (GIK) in the reduction of acute myocardial ischemia after an aortocoronary bypass intervention].
    Dainese L; Polvani GL; Fumero A; Spirito R; Alamanni F; Agrifoglio M; Parolari A; Biglioli P
    G Ital Cardiol; 1999 May; 29(5):575-9; discussion 580-2. PubMed ID: 10367228
    [No Abstract]   [Full Text] [Related]  

  • 8. Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.
    Schipke JD; Friebe R; Gams E
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):479-85. PubMed ID: 16481185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial protection of insulin and potassium in a porcine ischemia-reperfusion model.
    Oates A; Nubani R; Smiley J; Kistler L; Hughey S; Theiss P; Perez-Tamayo RA; Eiferman D; Lonchyna V; Higgins RS
    Surgery; 2009 Jul; 146(1):23-30. PubMed ID: 19541007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions.
    Lazar HL
    Am J Cardiol; 1997 Aug; 80(3A):90A-93A. PubMed ID: 9293960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolism: pharmacological manipulation in myocardial ischaemia.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jun; 53():552-60. PubMed ID: 16121812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic therapy in cardiac surgery--"Optimizing the engine's fuel supply and more...".
    Doenst T; Amorim PA
    Scand Cardiovasc J; 2010 Feb; 44(1):4-8. PubMed ID: 20141343
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery.
    Svedjeholm R; Håkanson E; Vanhanen I
    Ann Thorac Surg; 1995 Feb; 59(2 Suppl):S15-22. PubMed ID: 7840694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation.
    Sack MN; Yellon DM
    J Am Coll Cardiol; 2003 Apr; 41(8):1404-7. PubMed ID: 12706939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
    Lee L; Horowitz J; Frenneaux M
    Eur Heart J; 2004 Apr; 25(8):634-41. PubMed ID: 15084367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W; Lopaschuk GD
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced preservation of acutely ischemic myocardium using glucose-insulin-potassium solutions.
    Lazar HL
    J Card Surg; 1994 May; 9(3 Suppl):474-8. PubMed ID: 8069039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin in acute coronary syndromes].
    Halimi S
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():63-70. PubMed ID: 15666485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and insulin influences on heart and brain in cardiac surgery.
    Quinn DW; Pagano D; Bonser RS
    Semin Cardiothorac Vasc Anesth; 2005 Jun; 9(2):173-8. PubMed ID: 15920645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.